Sabra Health Care REIT, Inc. (SBRA) on Thursday updated its 2013 guidance to take into account the issuance of $200 million of 2023 Notes, redemption of $113.8 million of the 2018 Notes and investments through March 31, 2013 of $17.5 million.
In addition, the updated 2013 guidance no longer contemplates an issuance of $75.0 to $100.0 million of equity securities in 2013.
For fiscal 2013, the company now expects FFO to range between $1.53 and $1.57 per share and Normalized FFO, after adjusting for the redemption premium, write-off of deferred financing costs and issuance premiums associated with the redemption of $113.8 million of the 2018 Notes, to range between $1.79 and $1.83 per common share.
The company expects AFFO for fiscal 2013 to range between $1.42 and $1.46 per share and Normalized AFFO, after adjusting for the redemption premium, to range between $1.66 and $1.70 per share.
The company also said it now expects net income attributable to common stockholders for fiscal 2013 to range between $0.65 and $0.69 per share.
Analysts polled by Thomson Reuters currently expect the company to report FFO of $1.88 per share for the full year 2013. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com